RTTNews | Sep 20, 2021 07:05AM EDT

07:05 Monday, September 20, 2021 (RTTNews) - AVEO Oncology Says US FDA Grants Fast Track Designation To Ficlatuzumab For R/R Head And Neck Squamous Cell Carcinoma

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved